KRAS is a prognostic biomarker associated with diagnosis and treatment in multiple cancers
Abstract KRAS encodes K-Ras proteins, which take part in the MAPK pathway. The expression level of KRAS is high in…
Abstract KRAS encodes K-Ras proteins, which take part in the MAPK pathway. The expression level of KRAS is high in…
Keywords: LAML, Acute Myeloid Leukemia, BLCA, Bladder Urothelial Carcinoma, BRCA, Breast invasive carcinoma, CESC, Cervical squamous cell carcinoma and endocervical…
Abstract Forkhead box Q1 (FOXQ1) is a member of the forkhead transcription factor family involved in the occurrence and development…
Abstract Background: N6-methyladenosine (m6A) modification is a dynamic and reversible post-transcriptional RNA modification prevalent in eukaryotic cells. YT521-B homology domain…
Abstract Hepatocellular carcinoma (HCC) is known to have a poor prognosis. Accumulating evidence indicates that RRM2 plays a critical role…
Abstract Increasing studies have revealed significant associations between TOP2A with oncogenesis and prognosis of human cancers; however, pan-cancer analysis has…
Abstract Background: Transient receptor potential melastatin 8 (TRPM8) modulates tumor biology and sensitivity to treatment. The present study aimed to…
Abstract Background: The majority of drug-resistant cells in Thyroid cancer (THCA) tend to exhibit an Epithelial mesenchymal transition (EMT) phenotype,…
Abstract Sterile alpha motif (SAM) and Src homology-3 (SH3) domain-containing 3 (SASH3) is an adaptor protein expressed mainly in lymphocytes,…
Abstract Background: Hepatocellular carcinoma (HCC) is the predominant form of liver cancer and is accompanied by a complex regulatory network.…